Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)

Clinical trial NCT00942864 · COMPLETED

Trial details

NCT number: NCT00942864
Sponsor: Novartis Korea Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Edema Retinal Vein Occlusion

Start date: 2008-12-01
Primary completion: 2009-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.